Revlon ethicals
Executive Summary
Among firms reportedly showing initial interest in USV and/or Armour are Rorer and Boots. Another logical candidate would be Boehringer-Mannheim, which has recently established a new research effort in the U.S., has a well-stocked pipeline and could use an established drug sales force.